Evidence map›Paper›PMID 36651285›Full record

ArticleNucleic acids research2023

Dynamic states of eIF6 and SDS variants modulate interactions with uL14 of the 60S ribosomal subunit.

Jonah Elliff, Aparna Biswas, Poonam Roshan, Sahiti Kuppa, Angela Patterson, Jenna Mattice, Mathivanan Chinnaraj, Ryan Burd, Sarah E Walker, Nicola Pozzi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jonah ElliffDepartment of Biological Sciences, Marquette University, Milwaukee, WI 53233, USA.
Aparna BiswasDepartment of Biology, Saint Louis University, St. Louis, MO 63103, USA.
Poonam RoshanDepartment of Biology, Saint Louis University, St. Louis, MO 63103, USA.
Sahiti KuppaDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA.
Angela PattersonDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA.
Jenna MatticeDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA.
Mathivanan ChinnarajDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA.ORCID 0000-0002-7749-7364
Ryan BurdDepartment of Biological Sciences, Marquette University, Milwaukee, WI 53233, USA.
Sarah E WalkerDepartment of Biological Sciences, State University of New York, Buffalo, NY 14260, USA.ORCID 0000-0002-9983-2485
Nicola PozziDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA.ORCID 0000-0003-2309-7100
Edwin AntonyDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, MO 63104, USA.ORCID 0000-0002-1888-054X
Brian BothnerDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0003-1295-9609
Sofia OrigantiDepartment of Biology, Saint Louis University, St. Louis, MO 63103, USA.ORCID 0000-0002-6953-0160
Saint Louis University · USMontana State University · USMarquette University · USUniversity at Buffalo, State University of New York · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Jeffrey Good · 2012 to 2026
$60.0M
Coordination of DNA Metabolism by Replication Protein AR35GM149320 · NIGMS · SAINT LOUIS UNIVERSITY · PI Edwin Antony · 2023 to 2026
$2.3M
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid SyndromeR01HL150146 · NHLBI · SAINT LOUIS UNIVERSITY · PI POZZI, NICOLA · 2020 to 2024
$2.0M
Mechanism and Regulation of eIF6 in TranslationR01GM143179 · NIGMS · SAINT LOUIS UNIVERSITY · PI Sofia Origanti · 2022 to 2026
$1.8M
Molecular mechanisms of eukaryotic translational controlR01GM139977 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Sarah Elizabeth Walker · 2022 to 2026
$1.8M
Supplement Request for a FluorometerR01GM133967 · NIGMS · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2019 to 2023
$1.5M
Mechanisms of DNA hand-off during lesion repair in BER and NER supplementR01GM130746 · NIGMS · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2019 to 2022
$1.4M
Translational control by the eIF4 factorsR00GM119173 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WALKER, SARAH ELIZABETH · 2015 to 2017
$746k
Ultra Performance Liquid Chromatography Tandem Mass Spectrometer for MetabolomicsS10OD028650 · OD · MONTANA STATE UNIVERSITY - BOZEMAN · PI BOTHNER, BRIAN P · 2020 to 2020
$599k
Acquisition of an Optima Analytical UltracentrifugeS10OD030343 · OD · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2021 to 2021
$515k
Role and Regulation of eIF6 in TranslationR15GM126477 · NIGMS · SAINT LOUIS UNIVERSITY · PI ORIGANTI, SOFIA · 2018 to 2018
$452k
NCI NIH HHS P30 CA091842NHLBI NIH HHS R01 HL150146NIGMS NIH HHS P20 GM103474NIGMS NIH HHS R00 GM119173NIGMS NIH HHS R01 GM130746NIGMS NIH HHS R01 GM133967NIGMS NIH HHS R01 GM139977NIGMS NIH HHS R01 GM143179NIGMS NIH HHS R15 GM126477NIGMS NIH HHS R35 GM149320NIH HHS S10 OD028650NIH HHS S10 OD030343
6 · The paper itself

Abstract

Assembly of ribosomal subunits into active ribosomal complexes is integral to protein synthesis. Release of eIF6 from the 60S ribosomal subunit primes 60S to associate with the 40S subunit and engage in translation. The dynamics of eIF6 interaction with the uL14 (RPL23) interface of 60S and its perturbation by somatic mutations acquired in Shwachman-Diamond Syndrome (SDS) is yet to be clearly understood. Here, by using a modified strategy to obtain high yields of recombinant human eIF6 we have uncovered the critical interface entailing eight key residues in the C-tail of uL14 that is essential for physical interactions between 60S and eIF6. Disruption of the complementary binding interface by conformational changes in eIF6 disease variants provide a mechanism for weakened interactions of variants with the 60S. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) analyses uncovered dynamic configurational rearrangements in eIF6 induced by binding to uL14 and exposed an allosteric interface regulated by the C-tail of eIF6. Disrupting key residues in the eIF6-60S binding interface markedly limits proliferation of cancer cells, which highlights the significance of therapeutically targeting this interface. Establishing these key interfaces thus provide a therapeutic framework for targeting eIF6 in cancers and SDS.

Indexed as

Eukaryotic Initiation FactorsHumansRibosomal ProteinsRibosome Subunits, Large, EukaryoticShwachman-Diamond SyndromeEIF6 protein, humanEukaryotic Initiation FactorsRibosomal Proteins

Identifiers

PMID36651285
PMCPMC9976893
OpenAlexW4317209178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.